During tendon healing, it is postulated that intrinsic tendon cells drive tissue regeneration while extrinsic cells drive pathological scar formation. Intrinsic tendon cells are frequently described as a homogenous, fibroblast population that is positive for the marker Scleraxis. It is controversial whether intrinsic Scleraxis localize within the forming scar tissue during adult tendon healing.
Introduction
Tendon is a dense connective tissue that transmits force from muscle to bone. The transmission of force is facilitated by the tendon's structure, which consists of an aligned and organized type I collagen extracellular matrix. Following adult acute tendon injury, tendon function is disrupted by the generation of scar tissue, a highly disorganized extracellular matrix consisting of primarily type III collagen. The scar tissue fails to be fully remodeled during healing, impeding tendon function and increasing the incidence of post-operative tendon rupture.
Despite the prevalence of acute tendon injuries, the cellular components and molecular mechanisms driving scar formation during tendon healing have not been extensively characterized.
Localization and function of the various cell populations present during tendon healing are still contested. Better understanding of the intrinsic tendon cell population (i.e. resident tendon fibroblasts) and extrinsic populations (i.e. inflammatory cells, non-tendon mesenchymal cells) during tendon healing could inform identification of biological therapeutics. Fetal and neonatal tendons have increased recruitment of native tendon fibroblasts (tenocytes) to the defect site and exhibit regenerative capacities following an acute injury [1] [2] [3] , whereas injuries in adult animals exhibit a decreased recruitment of intrinsic cells and heal with scar [3] . Therefore, it is often the extrinsic cells that are implicated in scar tissue formation, increasing interest in how to harness the regenerative capabilities of intrinsic tendon cells. Despite the potential role of tenocytes in tendon regeneration, the localization of these cells during healing is debated.
Tenocytes are typically regarded as a homogenous population positive for the marker Scleraxis (Scx). Scx is a basic helix-loop-helix transcription factor that directs expression of extracellular matrix components and is necessary for the proper development of forcetransmitting tendons [4] [5] [6] . The localization of Scx+ cells during healing differs greatly between specific tendons and injury models, with some studies showing Scx+ cells localized at and bridging the defect site [7, 8] while others exhibit a complete absence of Scx+ cells within the scar [3] . No studies have extensively characterized Scx lineage cell localization in either a flexor tendon injury model or a model of complete transection and repair.
In potential contradiction to the notion of a homogeneous resident tendon cell population, we have recently demonstrated that S100a4 marks a high proportion of intrinsic tendon cells [9, 10] . However, the relationship between the Scx and S100a4 populations is unclear both during tendon homeostasis, and in response to injury. We hypothesized that in a model of complete transection and repair of the flexor tendon, Scx+ populations will localize within the scar tissue and that Scx would mark a separate population from the S100a4 cells during homeostasis and healing. In the current study, we characterized the localization of adult Scx-lineage cells during tendon healing, utilizing different labeling schemes to assess a variety of Scx+ populations. In addition, we have examined the relationship between Scx+ and S100a4+ cells during homeostasis and throughout tendon healing and assessed the potential of Scx-lineage cells to take on a terminal myofibroblast fate.
Methods

Animals Ethics
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal procedures were approved by the University Committee on Animal Research (UCAR) at the University of Rochester.
Mouse Models
Scx-Cre ERT2 mice were generously provided by Dr. Ronen Schweitzer. C57Bl/6J (#000664), ROSA-Ai9 (#007909), and S100a4-GFP (#012893) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). ROSA-Ai9 mice express Tomato red fluorescence in the presence of Cre-mediated recombination [11] . S100a4-GFP mice express eGFP under control of the S100a4 promoter [12] . Scx-Cre ERT2 mice were crossed to the ROSA-Ai9 to trace Scx-expressing cells (Scx Ai9 ). Scx Ai9 animals received three 100mg/kg i.p. tamoxifen injections at the times outlined in all figures.
Flexor Tendon Repair
At 10-12 weeks of age, mice underwent complete transection and repair of the flexor digitorum longus (FDL) tendon in the hindpaw as previously described [13] . Briefly, mice were injected prior to surgery with 15-20μg of sustained-release buprenorphine. Mice were then anesthetized with Ketamine (60mg/kg) and Xylazine (4mg/kg). Following sterilization of the surgery region, the FDL tendon was transected at the myotendinous junction to reduce strain-induced rupture of the repair site and the skin was closed with a 5-0 suture. A small incision was then made on the posterior surface of the hindpaw, the FDL tendon was located and completely transected using micro spring-scissors. The tendon was repaired using an 8-0 suture and the skin was closed with a 5-0 suture. Following surgery, animals resumed prior cage activity, food intake, and water consumption.
Histology -Frozen
Hindpaws were harvested from uninjured, 7, 14, and 21 days post-repair for frozen sectioning.
Hindpaws were fixed in 10% formalin for 24 hours at 4 o C, decalcified in 14% EDTA for 4 days at 4 o C, and processed in 30% sucrose for 24 hours at 4 o C to cryo-protect the tissue. Samples were then embedded in Cryomatrix (ThermoFisher, Waltham, MA) and sectioned into 8µm sagittal sections using a cryotape-transfer method [14] . Sections were mounted on glass slides using 1% chitosan in 0.25% acetic acid and counterstained with the nuclear stain DAPI.
Endogenous fluorescence was imaged on a VS120 Virtual Slide Microscope (Olympus, Waltham, MA). Images are representative of 3-4 specimens per time-point.
Histology -Paraffin
Hindpaws were harvested from C57Bl/6J mice for uninjured, 7, 14, 21, and 28 days post-repair time-points and from Scx Lin mice at day 14 post-repair for paraffin sectioning. Hindpaws were fixed in 10% formalin for 72 hours at room temperature, decalcified in 14% EDTA for two weeks, processed and embedded in paraffin. Three-micron sagittal sections were cut, de-waxed, rehydrated, and probed with antibodies for Scx (1:100, Cat#: ab58655, Abcam, Cambridge, MA), Red fluorescent protein (RFP) (1:500, Cat#: ab62341, Abcam, Cambridge, MA) and 
Results
Scleraxis lineage cells contribute to highly organized bridging tissue within scar during flexor tendon repair.
To label the Scleraxis lineage cell population prior to injury, Scx Ai9 mice were injected with tamoxifen for three days followed by a four day washout period immediately prior to surgery (Scx Lin ). Specimens were harvested at days 7, 14, and 21 post-surgery ( Fig. 1A & B ). In uninjured tendons, Scx Lin cells represented the majority of the total tendon cell population (Fig.   1C ). By 7 days following repair, Scx Lin cells resided within the tendon body and were not found in the scar tissue. The epitenon expanded in size and remained absent of Scx Lin cells ( Fig. 1D ).
By day 14, Scx Lin cells were organized into an aligned bridging tissue that spanned the width of the scar tissue and these cells appeared to emanate from the epitenon, which also comprised of Scx Lin cells ( 
Scleraxis Expression is Biphasic During Early Tendon Healing.
To assess the localization of cells expressing Scleraxis immediately after injury, mice were injected with tamoxifen on days 0-2 following repair ( Fig. 2A ). The localization of Scx Ai9 cells in the uninjured contralateral control tendon when labelling was performed from days 0-2 postsurgery (Scx 0-2 ) was comparable to Scx Ai9 expression when labelling was performed prior to surgery (Scx lin ) ( Fig. 2B ). No Scx 0-2 cells were found within the scar tissue in three out of four samples and there were fewer Scx 0-2 cells altogether compared to Scx Lin (Fig. 2C & C' ). To assess localization of cells expressing Scleraxis in the early proliferative stage of healing, mice were injected with tamoxifen on days 5-7 following repair ( Fig. 2D ). Localization of Scx Ai9 cells in the contralateral control with Scx 5-7 tendon was also comparable to Scx Lin ( Fig. 2E ). At 14 days following repair, Scx 5-7 cells were found within the scar tissue at the injury site, similar to Scx Lin (Fig. 2F & F' ). Thus, different induction schemes label different tendon cell populations, suggesting changes in Scx expression post-repair.
Scleraxis and S100a4 label distinct and overlapping tendon cells, demonstrating that tenocytes are a heterogenous population.
Scx Lin cells clearly mark an adult resident tendon cell population, and we have previously demonstrated that S100a4 is also expressed by many of these cells [9, 10], however, the relationship between these two populations is unclear. To address this, Scx Ai9 mice were crossed to S100a4 GFP mice to generate Scx Ai9 S100a4 GFP animals ( Fig 3A) . In this model, cells expressing Scx fluoresce red following tamoxifen injection while all cells actively expressing S100a4 fluoresce green. To assess the resident tendon cell populations independent of injury, uninjured tendons were used. Mice were injected with tamoxifen three times and allowed to washout for four days before harvest (Scx Lin S100a4 GFP ) ( Fig 3B) . Four individual tendon cell populations were identified: Scx Lin , S100a4 GFP , Scx Lin ;S100a4 GFP , and a dual-negative population. This data highlights previously unappreciated heterogeneity within the adult tendon cell population.
Scleraxis and S100a4 cell populations localize differently during flexor tendon repair.
We next sought to characterize the localization of these cell populations relative to one another during flexor tendon healing. Mice were injected with tamoxifen using the washout scheme ( Fig   4A) . At 14 days post-repair, Scx Lin cells were primarily localized to the tendon stubs and periphery of the scar tissue while S100a4 GFP cells were localized throughout the entire scar tissue area. Scx Lin ;S100a4 GFP cells were present at the tendon stubs and sparsely in the scar tissue. ( Fig   4B) . By 21 days post-repair, the Scx Lin population had expanded and was specific to the bridging scar tissue and tendon stubs. Interestingly, S100a4 GFP cells were found both within the organized bridging scar tissue exhibiting an elongated morphology and throughout the disorganized scar tissue with a rounded morphology. Dual-expressing Scx Lin ;S100a4 GFP cells were found prevalently in the bridging tissue at 21 days post-repair ( Fig 4C, C' & C"). To assess if some of these dual-expressing cells were still actively expressing Scx throughout healing, we injected Scx Ai9 ;S100a4 GFP mice with tamoxifen at days 10-12 to label cells expressing Scx nearly two weeks into healing (Scx 10-12 ) ( Fig 4D) . When harvested at 14 days post-repair, Scx 10-12 cells were still present within the tendon stubs and bridging tissue. Some of these cells were positive for both markers, indicating that a subset of cells later in healing are still expressing both Scx and S100a4 ( Fig 4E) .
Scleraxis lineage cells do not primarily differentiate into myofibroblasts during healing.
It has previously been shown that Scx can drive α SMA+ myofibroblast differentiation in the heart [15] . To investigate the ability of Scx Lin cells in the tendon to differentiate into myofibroblasts, we performed co-immunofluorescence of RFP and α SMA on day 14 post-repair sections ( Fig 5A) . A small proportion of Scx Lin cells expressed α SMA within the tendon stub, with nearly no Scx Lin cells expressing α SMA within the bridging scar tissue ( Fig 5B) .
Additionally, most α SMA+ myofibroblasts were not expressing RFP, suggesting that the majority of myofibroblasts are not derived from the Scx Lin cells.
Discussion
In the present study, we assessed the localization of Scx lineage cells throughout flexor tendon healing and examined the relationship between Scx and S100a4 cell populations during tendon homeostasis and healing. We have established that Scx lineage cells localize within the scar tissue in a highly aligned and organized manner with Scx expression occurring in a biphasic pattern, in a model of complete transection and repair of the flexor tendon. We have also shown that while Scx and S100a4 are both expressed in a subset of resident tendon cells, there are also populations that express only one of these markers, as well as a double negative population, thus identifying much greater heterogeneity of the resident tendon cell population than previously appreciated. In addition, Scx+ and S100a4+ cells localize differently during tendon injury, suggesting differential roles for these cells during tendon healing. Additionally, previous work has shown that α SMA lineage cells mark a subset of Scx+ tendon cells in uninjured patellar tendon [16] . We have previously shown that the calcium binding protein S100a4, which has been implicated in pathological fibrosis in a variety of tissues, labels a subset of intrinsic tendon cells and is present within the scar tissue during flexor tendon healing [9, 10] . Additionally, conditional deletion of EP4 in S100a4-lineage and Scx-lineage cells results in distinct phenotypes during tendon healing, suggesting these may represent discreet cell populations [9] . Consistent with this, dual tracing of Scx and S100a4 demonstrated that there are at least four distinct tendon cell sub-populations during homeostasis: Scx Lin , S100a4 GFP , Scx Lin ;S100a4 GFP , and a dual-negative population. Taken together, these findings demonstrate that intrinsic tendon cells are not a homogenous population. While future studies will be needed to delineate the potential discreet functions of these populations during tendon homeostasis, the dual-negative cell population may represent a non-fibroblast resident cell population.
Our data also suggest some divergence in the spatial localization of S100a4 and Scx cells during healing, suggesting they may be performing divergent functions. By 21 days post-repair, the Scx Lin cells were highly specific to the tendon stubs and bridging region of the scar tissue.
Interestingly, the S100a4 cell population is found both within the organized bridging scar tissue with an elongated cellular morphology similar to Scx Lin cells, and within the peripheral scar tissue exhibiting a rounded morphology. The relative contribution of tendon-derived S100a4 + cells and extrinsic S100a4 + cells is currently unknown, however, the differences in cellular morphology may be indicative of discreet S100a4 populations that originate from different sources and perform divergent functions during healing.
Scx drives expression of extracellular matrix components, including fibrillar collagens and fibronectin [4, 5, 20] . In pathological settings, fibroblasts can differentiate into contractile myofibroblasts that produce extracellular matrix proteins and aid in wound closure [21, 22] found that a subset of Scx lineage cells differentiated into myofibroblasts [24] . However, the majority of myofibroblasts were derived from a different source, suggesting that Scx may drive the differentiation of another cell population into myofibroblasts. We have recently shown that a subset of S100a4 lineage (S100a4 Lin ) cells differentiate into α SMA+ myofibroblasts following tendon injury and repair [10] . However, S100a4 GFP cells are not α SMA+, suggesting that S100a4 Lin cells may be downregulating S100a4 and differentiating into myofibroblasts following injury [10] . The influence of Scx on S100a4 myofibroblast differentiation has not been evaluated.
This study clearly demonstrates that Scx Lin cells localize within the scar tissue following flexor tendon repair and that Scx Lin cells represent a separate population from the S100a4 GFP cells, highlighting tendon cell heterogeneity. However, there are a few limitations that must be considered. First, while we administered several tamoxifen induction schemes to capture varying Scx+ cell populations, a complete assessment of current Scx expression was not evaluated.
Secondly, we did not look any later than day 21 post-repair, and therefore did not investigate the localization of Scx Lin and S100a4 GFP later in healing. Lastly, for our Scx Lin trace we allow four days for tamoxifen washout before tendon repair. The half-life of tamoxifen is approximately 12-16 hours [25, 26] , resulting in 0.39-1.56% of the original tamoxifen still residing in the Scx Lin mice at the time of tendon repair. As a result of these trace amounts of tamoxifen, we cannot state with complete certainty that the Scx Lin trace is not labeling a few newly activated Scx+ cells. However, when tamoxifen was administered and allowed to washout for four weeks (Scx Lin,4W ), the Scx Lin,4W population was comparable to the Scx Lin data, suggesting that 4 days is sufficient for tamoxifen washout (Fig S1) . Additionally, Scx Lin and Scx 0-2 exhibit different localization patterns, further suggesting that a short tamoxifen washout period is adequate.
Altogether, these data demonstrate that the Scx Lin cell population localize within the scar tissue and form a highly aligned bridging tissue that resembles native tendon in its organization.
This contrasts with the S100a4 GFP population that is disorganized and present throughout the entire scar tissue. This suggests that the intrinsic Scx Lin cells may be driving organized regenerative healing while S100a4 GFP cells contribute to the formation of scar. Designing strategies to harness intrinsic cells during adult tendon repair may help in driving tendon regeneration, and a better understanding of the discrete intrinsic cell populations within tendon will help inform on targeted therapies to positively affect healing. Scx Ai9 mice were crossed to S100a4 GFP mice (Scx Ai9 S100a4 GFP ) to allow dual tracing of Scleraxis lineage and S100a4+ cell populations (A). Scx Ai9 S100a4 GFP mice were injected with TAM on three consecutive days and harvested 18 days following the final injection (B). Uninjured Scx Ai9 S100a4 GFP tendons exhibit four distinct cell types with colored arrows indicating examples of each: Scx Lin (red arrow), S100a4 GFP (green arrow), Scx Lin ; S100a4 GFP (yellow arrow), and dualnegative populations (blue arrow) (C). Nuclear stain DAPI is blue. Scx Ai9 ; S100a4 GFP mice were injected with TAM on three consecutive days and allowed to washout for four days prior to repair (A). Scx Lin ; S100a4 GFP mice were harvested at 14 (B) and 21 (C) days post-repair. Insets indicate linear (C') and rounded (C") morphology of S100a4 GFP cells. Scx Ai9 ; S100a4 GFP mice were injected with TAM on days 10-12 post-repair (D) to generate Scx 10-12 ; S100a4 GFP mice and were harvested at day 14 (E). Tendon is outlined by white dotted lines and scar tissue by yellow dotted lines. 
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